Is Pacific Biosciences of California Inc (NASDAQ: PACB) Back In The Buying Zone?
Currently, there are 300.04M common shares owned by the public and among those 264.16M shares have been available to trade. The company’s stock has a 5-day price change of -13.04% and -9.77% over the past three months. PACB shares are trading -23.57% year to date (YTD), with the 12-month market performance down to -34.43% lower. […]
These Numbers Could Change Investor Views For Pacific Biosciences of California Inc (NASDAQ: PACB)
Currently, there are 300.04M common shares owned by the public and among those 264.16M shares have been available to trade. The company’s stock has a 5-day price change of 15.00% and 11.29% over the past three months. PACB shares are trading -24.59% year to date (YTD), with the 12-month market performance down to -30.30% lower. […]
Pacific Biosciences of California Inc (PACB) Volatility Spurs A Quest For Clarity
Currently, there are 300.04M common shares owned by the public and among those 264.16M shares have been available to trade. The company’s stock has a 5-day price change of 18.29% and -14.29% over the past three months. PACB shares are trading -37.70% year to date (YTD), with the 12-month market performance down to -36.67% lower. […]
Is Pacific Biosciences of California Inc (NASDAQ: PACB) Back In The Buying Zone?
Currently, there are 300.04M common shares owned by the public and among those 264.16M shares have been available to trade. The company’s stock has a 5-day price change of 15.36% and -22.22% over the past three months. PACB shares are trading -42.62% year to date (YTD), with the 12-month market performance down to -45.88% lower. […]
Reassessing The Changing Outlook For Pacific Biosciences of California Inc (PACB)
Currently, there are 300.04M common shares owned by the public and among those 264.16M shares have been available to trade. The company’s stock has a 5-day price change of -10.76% and -41.65% over the past three months. PACB shares are trading -50.26% year to date (YTD), with the 12-month market performance down to -50.80% lower. […]
Pacific Biosciences of California Inc (NASDAQ: PACB): Hunting Genuine Value In Market Debris
Currently, there are 300.04M common shares owned by the public and among those 264.15M shares have been available to trade. The company’s stock has a 5-day price change of -7.59% and -44.05% over the past three months. PACB shares are trading -43.44% year to date (YTD), with the 12-month market performance down to -53.59% lower. […]
Pacific Biosciences of California Inc (NASDAQ: PACB): The Best-Of-Breed For Investing?
Currently, there are 300.04M common shares owned by the public and among those 264.11M shares have been available to trade. The company’s stock has a 5-day price change of -0.90% and -17.29% over the past three months. PACB shares are trading -39.89% year to date (YTD), with the 12-month market performance down to -34.52% lower. […]
Gains May Be On The Menu For Pacific Biosciences of California Inc (NASDAQ: PACB)
Currently, there are 294.42M common shares owned by the public and among those 264.11M shares have been available to trade. The company’s stock has a 5-day price change of -0.90% and -23.61% over the past three months. PACB shares are trading -39.89% year to date (YTD), with the 12-month market performance down to -37.50% lower. […]
Pacific Biosciences of California Inc (PACB): A Great Stock For Handling Current Market Conditions?
Currently, there are 294.42M common shares owned by the public and among those 262.18M shares have been available to trade. The company’s stock has a 5-day price change of -0.88% and -32.34% over the past three months. PACB shares are trading -38.25% year to date (YTD), with the 12-month market performance down to -16.91% lower. […]
Reassessing The Changing Outlook For Pacific Biosciences of California Inc (PACB)
Currently, there are 294.42M common shares owned by the public and among those 262.18M shares have been available to trade. The company’s stock has a 5-day price change of -11.36% and -31.18% over the past three months. PACB shares are trading -36.07% year to date (YTD), with the 12-month market performance down to -19.86% lower. […]